Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 25:21:100276.
doi: 10.1016/j.sipas.2025.100276. eCollection 2025 Jun.

Simultaneous radical cystectomy and nephroureterectomy: A case series

Gavin G Calpin  1   2 , Steven M Anderson  1   2 , Mark Broe  1 , Ijaz Cheema  1 , Niall F Davis  1   2 , Dilly Little  1
Affiliations

Simultaneous radical cystectomy and nephroureterectomy: A case series

Gavin G Calpin et al. Surg Pract Sci. .

Abstract

Introduction: Simultaneous radical cystectomy and nephroureterectomy (RCNU) is a complex procedure. Although performed infrequently, RCNU may be indicated in certain cases of multifocal high grade urothelial carcinoma (UC) or muscle-invasive bladder cancer (MIBC) with an obstructed and atrophic kidney. The aim of this study was to review the indications, operative approach and outcomes for patients undergoing RCNU in our institution.

Methods: A single-centre, retrospective review was performed. Cases were identified by reviewing theatre logbooks. Chart reviews were conducted and clinicopathological outcomes were recorded and analysed.

Results: Eight patients were identified between 2015-2024. All were male and had a mean age of 66.4 ± 4.7 years. All patients underwent RCNU with ileal conduit formation. The surgical approach for the nephroureterectomy was laparoscopic in four cases and open in the remaining four. The mean post-operative length of stay was 11.6 ± 1.75 days. All patients had high grade UC, seven patients had MIBC at presentation. Only two patients received neoadjuvant chemotherapy, one of whom achieved a complete pathological response. In total, 62.5% (n=5) had T3/4 disease while 50% (n=4) had node positive disease. Two patients had synchronous upper tract urothelial carcinoma (UTUC) on final histology. The remaining cases had chronically obstructed and atrophic kidneys. Incidental primary prostate cancer was found in 62.5% (n=5). The mean follow-up was 31.6 ± 7 months, during which time there were four recurrences with three patients dying from metastatic disease. The mean overall survival was 21.8 ± 11.8 months and the mean disease-free survival was 19.3 ± 12.3 months.

Conclusion: The results from this study demonstrate that combined laparoscopic and open RCNU is an effective treatment for both panurothelial cancer and MIBC with severe upper tract dysfunction.

Keywords: Nephroureterectomy; Outcomes; Radical cystectomy; Upper urinary tract; Urothelial cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Saginala K., Barsouk A., Aluru J.S., Rawla P., Padala S.A., Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel) 2020;8(1) - PMC - PubMed
    1. Hafner C., Knuechel R., Stoehr R., Hartmann A. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer. 2002;101(1):1–6. - PubMed
    1. Zein M., Nasrallah A.A., Abou Heidar N.F., Najdi J., Hneiny L., El Hajj A. Concurrent radical cystectomy and nephroureterectomy indications and outcomes: a systematic review and comparative analysis. Ther Adv Urol. 2023;15 - PMC - PubMed
    1. Barros R., Frota R., Stein R.J., Turna B., Gill I.S., Desai MM. Simultaneous laparoscopic nephroureterectomy and cystectomy: a preliminary report. Int Braz J Urol. 2008;34(4):413–421. discussion 21. - PubMed
    1. Liu Y., Zhang H., Wen Z., Jiang Y., Huang J., Wang C., et al. Simultaneous radical cystectomy and nephroureterectomy in the treatment of panurothelial carcinoma: a systematic review and single-arm meta-analysis. Front Oncol. 2023;13 - PMC - PubMed

LinkOut - more resources